Structure Therapeutics Inc.

Structure Therapeutics Inc.verified

GPCR

Price:

$37.06

Market Cap:

$1.73B

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pu...[Read more]

Industry

Biotechnology

IPO Date

2023-02-03

Stock Exchange

NASDAQ

Ticker

GPCR

The PE Ratio as of May 2024 (TTM) for Structure Therapeutics Inc. (GPCR) is -15.25

According to Structure Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -15.25. This represents a change of -18.42% compared to the average of -18.69 of the last 4 quarters.

Structure Therapeutics Inc. (GPCR) Historical PE Ratio (quarterly & annually)

How has GPCR PE Ratio performed in the past?

The mean historical PE Ratio of Structure Therapeutics Inc. over the last ten years is -21239.34. The current -15.25 PE Ratio has changed -92.82% with respect to the historical average. Over the past ten years (40 quarters), GPCR's PE Ratio was at its highest in in the March 2023 quarter at -7.90. The PE Ratio was at its lowest in in the December 2021 quarter at -10734.55.

Quarterly (TTM)
Annual

Average

-21239.34

Median

-12510.18

Minimum

-59920.28

Maximum

-16.72

Structure Therapeutics Inc. (GPCR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Structure Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = -16.72

Minimum Annual Increase = -99.93%

Minimum Annual PE Ratio = -59920.28

Quarterly (TTM)
Annual
YearPE RatioChange
2023-16.72-9.79%
2022-18.54-99.93%
2021-25001.82-58.27%

Structure Therapeutics Inc. (GPCR) Average PE Ratio

How has GPCR PE Ratio performed in the past?

The current PE Ratio of Structure Therapeutics Inc. (GPCR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-8345.69

5-year avg

-21239.34

10-year avg

-21239.34

Structure Therapeutics Inc. (GPCR) PE Ratio vs. Peers

How is GPCR’s PE Ratio compared to its peers?

Structure Therapeutics Inc.’s PE Ratio is less than Day One Biopharmaceuticals, Inc. (-5.71), less than X4 Pharmaceuticals, Inc. (-1.40), less than Inozyme Pharma, Inc. (-3.66), less than Acumen Pharmaceuticals, Inc. (-3.64), greater than Mereo BioPharma Group plc (-58.75), less than Terns Pharmaceuticals, Inc. (-4.90), less than Amylyx Pharmaceuticals, Inc. (-1.65), less than Eledon Pharmaceuticals, Inc. (-2.12), less than HOOKIPA Pharma Inc. (-2.11), less than Biomea Fusion, Inc. (-3.10), less than Disc Medicine, Inc. (-10.55), greater than DICE Therapeutics, Inc. (-23.17), less than Morphic Holding, Inc. (-9.55),

Build a custom stock screener for Structure Therapeutics Inc. (GPCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Structure Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Structure Therapeutics Inc. (GPCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Structure Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Structure Therapeutics Inc.'s PE Ratio?

How is the PE Ratio calculated for Structure Therapeutics Inc. (GPCR)?

What is the highest PE Ratio for Structure Therapeutics Inc. (GPCR)?

What is the 3-year average PE Ratio for Structure Therapeutics Inc. (GPCR)?

What is the 5-year average PE Ratio for Structure Therapeutics Inc. (GPCR)?

How does the current PE Ratio for Structure Therapeutics Inc. (GPCR) compare to its historical average?